All Stories

  1. Aberrant methylation and silencing of the SPINT2 gene in high-grade gliomas

    Article • Cancer Science, August 2018, Wiley

    Dr HIROAKI KATAOKA

  2. Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2): Emerging key players in epithelial integrity and cancer

    Article • Pathology International, February 2018, Wiley

    Dr HIROAKI KATAOKA

  3. HAI-2 stabilizes, inhibits and regulates SEA-cleavage-dependent secretory transport of matriptase

    Article • Traffic, May 2017, Wiley

    Dr HIROAKI KATAOKA

  4. Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer-associated fibroblasts by paracrine activation of protease-activated receptor 2

    Article • International Journal of Cancer, September 2016, Wiley

    Dr HIROAKI KATAOKA

  5. Ghrelin administration suppresses inflammation‐associated colorectal carcinogenesis in mice

    Article • Cancer Science, July 2015, Wiley

    Dr HIROAKI KATAOKA

  6. Expression of human kallikrein 1-related peptidase 4 (KLK4) and MET phosphorylation in prostate cancer tissue: immunohistochemical analysis

    Article • Human Cell, April 2015, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  7. High preoperative levels of serum glypican-3 containing N-terminal subunit are associated with poor prognosis in patients with hepatocellular carcinoma after partial hepatectomy

    Article • International Journal of Cancer, April 2015, Wiley

    Dr HIROAKI KATAOKA

  8. A case of a pleomorphic hyalinizing angiectatic tumor of soft parts with intracytoplasmic hemosiderin pigment apparent upon fine‐needle aspiration cytology

    Article • Diagnostic Cytopathology, November 2014, Wiley

    Dr HIROAKI KATAOKA

  9. Cutaneous paragonimiasis due to triploid Paragonimus westermani presenting as a non-migratory subcutaneous nodule: a case report

    Article • Journal of Medical Case Reports, October 2014, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  10. Tumor budding in colorectal carcinoma assessed by cytokeratin immunostaining and budding areas: Possible involvement of c‐Met

    Article • Cancer Science, October 2014, Wiley

    Dr HIROAKI KATAOKA

  11. Abstract LB-4: Ghrelin administration suppresses inflammation-associated colorectal carcinogenesis in mice

    Article • Cancer Research, September 2014, American Association for Cancer Research (AACR)

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  12. Abstract 4859: Hepatocyte growth factor activator inhibitor type 1 suppresses invasion of pancreatic adenocarcinoma cells through inhibition of matriptase/protease-activated receptor-2 axis

    Article • Cancer Research, September 2014, American Association for Cancer Research (AACR)

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  13. Mechanisms of Hepatocyte Growth Factor Activation in Cancer Tissues

    Article • Cancers, September 2014, MDPI AG

    Dr HIROAKI KATAOKA

  14. Matriptase and MET are prominently expressed at the site of bone metastasis in renal cell carcinoma: immunohistochemical analysis

    Article • Human Cell, September 2014, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  15. Emerging histopathological prognostic biomarkers in hepatocellular carcinomas

    Article • Personalized Medicine Universe, July 2014, Elsevier

    Dr HIROAKI KATAOKA

  16. Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma

    Article • Liver International, February 2014, Wiley

    Dr HIROAKI KATAOKA

  17. Duodenal mucosal damage is associated with proliferative activity of Brunner’s gland hamartoma: a case report

    Article • BMC Gastroenterology, January 2014, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  18. Identification of a Bioactive Compound against Adult T-cell Leukaemia from Bitter Gourd Seeds

    Article • Plants, December 2013, MDPI AG

    Dr HIROAKI KATAOKA

  19. Carnosol, rosemary ingredient, induces apoptosis in adult T-cell leukemia/lymphoma cells via glutathione depletion: proteomic approach using fluorescent two-dimensional differential gel electrophoresis

    Article • Human Cell, December 2013, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  20. Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model

    Article • Cancer Science, November 2013, Wiley

    Dr HIROAKI KATAOKA

  21. Hepatocyte Growth Factor Activator Inhibitor-1 Is Induced by Bone Morphogenetic Proteins and Regulates Proliferation and Cell Fate of Neural Progenitor Cells

    Article • PLoS ONE, February 2013, PLOS

    Dr HIROAKI KATAOKA

  22. Abstract B24: Hepatocyte growth factor activator inhibitor type 1 (HAI-1) suppresses tumor growth and metastasis of pancreatic adenocarcinoma cells

    Article • Cancer Research, February 2013, American Association for Cancer Research (AACR)

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  23. Hepatocyte Growth Factor Activator

    Article • January 2013, Elsevier

    Dr HIROAKI KATAOKA

  24. Effect of dietary blueberry (Vaccinium ashei Reade) leaves on serum and hepatic lipid levels in rats

    Article • Journal of Oleo Science, January 2013, Japan Oil Chemists' Society

    Dr HIROAKI KATAOKA

  25. Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells

    Article • Human Cell, December 2012, Springer Science + Business Media

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  26. Urinary bladder pyogenic granuloma: a case report

    Article • Journal of Medical Case Reports, June 2012, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  27. HAI-1 regulates invasiveness of oral squamous cell carcinoma

    Article • The Journal of Pathology, April 2012, Wiley

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  28. Synchronous solid pseudopapillary neoplasm and intraductal papillary mucinous neoplasm of the pancreas: Report of a case

    Article • Surgery Today, May 2011, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  29. Inhibition of proliferation by agricultural plant extracts in seven human adult T-cell leukaemia (ATL)-related cell lines

    Article • Journal of Natural Medicines, February 2011, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  30. Hepatocyte growth factor activator inhibitor type 1 suppresses metastatic pulmonary colonization of pancreatic carcinoma cells

    Article • Cancer Science, January 2011, Wiley

    Dr HIROAKI KATAOKA

  31. Improvement of Rheumatoid Arthritis and Autoimmune Hepatitis in a Patient Treated with the Tumor Necrosis Factor Inhibitor, Etanercept

    Article • Internal Medicine, January 2011, Japanese Society of Internal Medicine

    Dr HIROAKI KATAOKA

  32. Suppressive roles of HAI-1 for pulmonary metastasis

    Article • Cancer Science, December 2010, Wiley

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  33. Prognostic significance of circumferential cell surface immunoreactivity of glypican-3 in hepatocellular carcinoma

    Article • Liver International, October 2010, Wiley

    Dr HIROAKI KATAOKA

  34. Hepatocyte growth factor activator (HGFA)

    Article • FEBS Journal, April 2010, Wiley

    Dr HIROAKI KATAOKA

  35. Hepatocyte growth factor activator (HGFA): pathophysiological functions in vivo

    Article • FEBS Journal, April 2010, Wiley

    Dr HIROAKI KATAOKA

  36. Expression of Hepatocyte Growth Factor Activator Inhibitor Type 1 in Human Hepatocellular Carcinoma and Postoperative Outcomes

    Article • World Journal of Surgery, March 2010, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  37. Imbalance in the Pro–Hepatocyte Growth Factor Activation System in Bleomycin-Induced Lung Fibrosis in Mice

    Article • American Journal of Respiratory Cell and Molecular Biology, March 2010, American Thoracic Society

    Dr HIROAKI KATAOKA

  38. Proanthocyanidin derived from the leaves ofVaccinium virgatumsuppresses platelet-derived growth factor-induced proliferation of the human hepatic stellate cell line LI90

    Article • Hepatology Research, March 2010, Wiley

    Dr HIROAKI KATAOKA

  39. Multiple Integrations of Human T-Lymphotropic Virus Type 1 Proviruses in the Engrafted Cells from the Asymptomatic Carriers in NOD/SCID/γcnull Mice

    Article • Intervirology, January 2010, Karger Publishers

    Dr HIROAKI KATAOKA

  40. The expression profile of glypican-3 and its relation to macrophage population in human hepatocellular carcinoma

    Article • Liver International, August 2009, Wiley

    Dr HIROAKI KATAOKA

  41. Hepatocyte growth factor activator is a serum activator of single-chain precursor macrophage-stimulating protein

    Article • FEBS Journal, June 2009, Wiley

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  42. Tissue injury alters the site of expression of hepatocyte growth factor activator inhibitor type 1 in bronchial epithelial cells

    Article • Human Cell, February 2009, Springer Science + Business Media

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  43. Dickkopf-1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involved in invasive growth

    Article • International Journal of Cancer, January 2009, Wiley

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  44. Establishment and characterization of a new human glioblastoma cells line, NYGM

    Article • Human Cell, October 2008, Springer Science + Business Media

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  45. Expression of hepatocyte growth factor activator inhibitor type 1 on the epithelial cell surface is regulated by hypoxic and oxidative stresses

    Article • Virchows Archiv, September 2008, Springer Science + Business Media

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  46. Activation of MET receptor tyrosine kinase in ulcer surface epithelial cells undergoing restitution

    Article • Pathology International, July 2008, Wiley

    Dr HIROAKI KATAOKA

  47. New entity, definition and diagnostic criteria of cutaneous adult T-cell leukemia/lymphoma: Human T-lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smoldering types

    Article • The Journal of Dermatology, May 2008, Wiley

    Dr HIROAKI KATAOKA

  48. Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases

    Article • FEBS Journal, January 2008, Wiley

    Dr HIROAKI KATAOKA

  49. Roles of Kunitz domains in the anti-invasive effect of hepatocyte growth factor activator inhibitor type 1 in human glioblastoma cells

    Article • Human Cell, November 2007, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  50. Main-duct intraductal papillary mucinous adenoma of the pancreas with a large mural nodule

    Article • International Journal of Clinical Oncology, October 2007, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  51. Soy-derived isoflavones inhibit the growth of adult T-cell leukemia cellsin vitroandin vivo

    Article • Cancer Science, August 2007, Wiley

    Dr HIROAKI KATAOKA

  52. Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma

    Article • Cancer Science, April 2007, Wiley

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  53. Engraftment of peripheral blood mononuclear cells from human T-lymphotropic virus Type 1 carriers in NOD/SCID/γcnull (NOG) mice

    Article • International Journal of Cancer, January 2007, Wiley

    Dr HIROAKI KATAOKA

  54. Augmented expression of hepatocytes growth factor activator inhibitor type 1 (HAI-1) in intrahepatic small bile ducts in primary biliary cirrhosis

    Article • Virchows Archiv, August 2006, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  55. Expression of hepatocyte growth factor activator inhibitor type 1 in endothelial cells

    Article • Human Cell, August 2006, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  56. Effect of hepatocyte growth factor on endogenous hepatocarcinogenesis in rats fed a choline-deficient L-amino acid-defined diet

    Article • Oncology Reports, July 2006, Spandidos Publications

    Dr HIROAKI KATAOKA

  57. Defect of Pro-Hepatocyte Growth Factor Activation by Fibroblasts in Idiopathic Pulmonary Fibrosis

    Article • American Journal of Respiratory and Critical Care Medicine, July 2006, American Thoracic Society

    Dr HIROAKI KATAOKA

  58. Human T-cell lymphotropic virus type I (HTLV-1) associated myelopathy and Sjögren's syndrome representing pulmonary nodular amyloidosis and multiple bullae: report of an autopsy case

    Article • Virchows Archiv, April 2006, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  59. Nuclear translocation of H2RSP is impaired in regenerating intestinal epithelial cells of murine colitis model

    Article • Virchows Archiv, September 2005, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  60. Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo

    Article • International Journal of Cancer, August 2005, Wiley

    Dr HIROAKI KATAOKA, Tsuyoshi Fukushima

  61. Adenoid glioblastoma arising in a patient with neurofibromatosis type-1

    Article • Pathology International, June 2005, Wiley

    Dr HIROAKI KATAOKA

  62. Multiple hepatic peribiliary cysts with cirrhosis

    Article • Journal of Gastroenterology, April 2004, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  63. Ovarian pregnancy: Report of four cases and review of the literature

    Article • Pathology International, November 2003, Wiley

    Dr HIROAKI KATAOKA

  64. Role of Cancer Cell-Stroma Interaction in Invasive Growth of Cancer Cells

    Article • Human Cell, February 2003, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  65. Hydroxyapatite Block for Use in Posterolateral Lumbar Fusion

    Article • Clinical Orthopaedics and Related Research, June 2002, Wolters Kluwer Health

    Dr HIROAKI KATAOKA

  66. Emerging multifunctional aspects of cellular serine proteinase inhibitors in tumor progression and tissue regeneration

    Article • Pathology International, February 2002, Wiley

    Dr HIROAKI KATAOKA

  67. Protein Kinase C-α and -ε Down-Regulate Cell Surface Sodium Channels via Differential Mechanisms in Adrenal Chromaffin Cells

    Article • Journal of Neurochemistry, January 2002, Wiley

    Dr HIROAKI KATAOKA

  68. Roles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa

    Article • Journal of Gastroenterology, January 2002, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  69. Cytology of Primary Cutaneous Langerhans Cell Histiocytosis with a Malignant Phenotype

    Article • Acta Cytologica, January 2002, Karger Publishers

    Dr HIROAKI KATAOKA

  70. Mouse Hepatocyte Growth Factor (HGF) Activator Inhibitor Type 2 Lacking the First Kunitz Domain Potently Inhibits the HGF Activator

    Article • Biochemical and Biophysical Research Communications, January 2002, Elsevier

    Dr HIROAKI KATAOKA

  71. Expression of Hepatocyte Growth Factor Activator and Hepatocyte Growth Factor Activator Inhibitor Type 1 in Human Hepatocellular Carcinoma

    Article • Biochemical and Biophysical Research Communications, November 2001, Elsevier

    Dr HIROAKI KATAOKA

  72. Solitary fibroleiomyomatous hamartoma of the lung in a patient without a pre-existing smooth-muscle tumor

    Article • Pathology International, August 2001, Wiley

    Dr HIROAKI KATAOKA

  73. Reduced expression of hepatocyte growth factor activator inhibitor type‐2/placental bikunin (HAI‐2/PB) in human glioblastomas: Implication for anti‐invasive role of HAI‐2/PB in glioblastoma cells

    Article • International Journal of Cancer, August 2001, Wiley

    Dr HIROAKI KATAOKA

  74. Mouse hepatocyte growth factor activator inhibitor type 1 (HAI-1) and type 2 (HAI-2)/placental bikunin genes and their promoters

    Article • Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, May 2001, Elsevier

    Dr HIROAKI KATAOKA

  75. Amyloid β protein precursor is involved in the growth of human colon carcinoma cellin vitro andin vivo

    Article • International Journal of Cancer, April 2001, Wiley

    Dr HIROAKI KATAOKA

  76. Amyloid β protein precursor is involved in the growth of human colon carcinoma cell in vitro and in vivo

    Article • International Journal of Cancer, April 2001, Wiley

    Dr HIROAKI KATAOKA

  77. Reduced expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin (HAI-2/PB) in human glioblastomas: Implication for anti-invasive role of HAI-2/PB in glioblastoma cells

    Article • International Journal of Cancer, January 2001, Wiley

    Dr HIROAKI KATAOKA

  78. Genomic structure and chromosomal localization of the human hepatocyte growth factor activator inhibitor type 1 and 2 genes

    Article • European Journal of Biochemistry, June 2000, Wiley

    Dr HIROAKI KATAOKA

  79. Successful treatment of a bronchial inflammatory pseudotumor by bronchoplasty in an 8-year-old boy: Report of a case

    Article • Surgery Today, May 2000, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  80. Reduced expression of hepatocyte growth factor (HGF) activator inhibitor type-1 and enhanced activation of hgf in the early stage gastrointestinal carcinomas

    Article • Gastroenterology, April 2000, Elsevier

    Dr HIROAKI KATAOKA

  81. Mouse hepatocyte growth factor activator gene: its expression not only in the liver but also in the gastrointestinal tract

    Article • Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, April 2000, Elsevier

    Dr HIROAKI KATAOKA

  82. Conserved expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin in human colorectal carcinomas

    Article • Cancer Letters, February 2000, Elsevier

    Dr HIROAKI KATAOKA

  83. Overexpression of intestinal trefoil factor in human colon carcinoma cells reduces cellular growth in vitro and in vivo

    Article • Gastroenterology, January 2000, Elsevier

    Dr HIROAKI KATAOKA

  84. Mutational analysis of human p53 gene in human gliomas by CleavaseR fragment length polymorphism

    Article • Neuropathology, September 1999, Wiley

    Dr HIROAKI KATAOKA

  85. Mutational analysis of human p53 gene in human gliomas by CleavaseR fragment length polymorphism

    Article • Neuropathology, September 1999, Wiley

    Dr HIROAKI KATAOKA

  86. Solitary fibrous tumor of the spinal nerve rootlet: Case report and literature survey

    Article • Pathology International, September 1999, Wiley

    Dr HIROAKI KATAOKA

  87. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP

    Article • International Journal of Cancer, July 1999, Wiley

    Dr HIROAKI KATAOKA

  88. Overexpression of Tissue Factor Pathway Inhibitor in Aortic Smooth Muscle Cells Inhibits Cell Migration Induced by Tissue Factor/Factor VIIa Complex

    Article • Thrombosis Research, June 1999, Elsevier

    Dr HIROAKI KATAOKA

  89. Hepatocyte Growth Factor Activator Inhibitor Type 2 Lacking the First Kunitz-Type Serine Proteinase Inhibitor Domain Is a Predominant Product in Mouse but Not in Human

    Article • Biochemical and Biophysical Research Communications, February 1999, Elsevier

    Dr HIROAKI KATAOKA

  90. Retroperitoneal bronchogenic cyst: Report of a case and literature review

    Article • Pathology International, February 1999, Wiley

    Dr HIROAKI KATAOKA

  91. Cholesterol Embolism in a Patient with Inflammatory Abdominal Aortic Aneurysm.

    Article • Internal Medicine, January 1999, Japanese Society of Internal Medicine

    Dr HIROAKI KATAOKA

  92. Carcinoembryonic Antigen and Carbohydrate Antigen 19-9-Producing Adenocarcinoma of the Prostate: Report of an Autopsy Case

    Article • Urologia Internationalis, January 1999, Karger Publishers

    Dr HIROAKI KATAOKA

  93. Hepatocyte growth factor/scatter factor induces not only scattering but also cohort migration of human colorectal-adenocarcinoma cells

    Article • International Journal of Cancer, December 1998, Wiley

    Dr HIROAKI KATAOKA

  94. TPA-induced cohort migration of well-differentiated human rectal adenocarcinoma cells: cells move in a RGD-dependent manner on fibronectin produced by cells, and phosphorylation of E-cadherin/catenin complex is induced independently of cell-extracellul...

    Article • Virchows Archiv, September 1998, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  95. Expression of tissue factor in the rabbit aorta after balloon injury

    Article • Atherosclerosis, August 1998, Elsevier

    Dr HIROAKI KATAOKA

  96. Up-regulation of Vascular Endothelial Growth Factor Induced by Hepatocyte Growth Factor/Scatter Factor Stimulation in Human Glioma Cells

    Article • Biochemical and Biophysical Research Communications, August 1998, Elsevier

    Dr HIROAKI KATAOKA

  97. Evaluation of hepatocyte growth factor activator inhibitor expression in normal and malignant colonic mucosa

    Article • Cancer Letters, June 1998, Elsevier

    Dr HIROAKI KATAOKA

  98. Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans

    Article • Cancer Letters, February 1998, Elsevier

    Dr HIROAKI KATAOKA

  99. Analysis of tissue factor and tissue factor pathway inhibitor expression in human colorectal carcinoma cell lines and metastatic sublines to the liver

    Article • International Journal of Cancer, September 1997, Wiley

    Dr HIROAKI KATAOKA

  100. Expression of bone morphogenetic proteins of human neoplastic epithelial cells

    Article • IUBMB Life, July 1997, Wiley

    Dr HIROAKI KATAOKA

  101. Hepatocellular carcinoma with sarcomatous change arising in primary biliary cirrhosis

    Article • Journal of Gastroenterology, January 1997, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  102. Feasibility of archival non-buffered formalin-fixed and paraffin-embedded tissues for PCR amplification: An analysis of resected gastric carcinoma

    Article • Pathology International, December 1996, Wiley

    Dr HIROAKI KATAOKA

  103. Human Keratinocytes Express EMMPRIN, an Extracellular Matrix Metalloproteinase Inducer

    Article • Journal of Investigative Dermatology, June 1996, Elsevier

    Dr HIROAKI KATAOKA

  104. Stimulation of gelatinase B and tissue inhibitors of metalloproteinase (TIMP) production in co-culture of human osteosarcoma cells and human fibroblasts: Gelatinase-B production was stimulated via up-regulation of fibroblast growth factor (FGF) receptor

    Article • International Journal of Cancer, March 1996, Wiley

    Dr HIROAKI KATAOKA

  105. Stimulation of gelatinase B and tissue inhibitors of metalloproteinase (TIMP) production in co‐culture of human osteosarcoma cells and human fibroblasts: Gelatinase‐B production was stimulated via up‐regulation of fibroblast growth factor (FGF) receptor

    Article • International Journal of Cancer, March 1996, Wiley

    Dr HIROAKI KATAOKA

  106. Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro

    Article • FEBS Letters, September 1995, Wiley

    Dr HIROAKI KATAOKA

  107. Reverse-zymographic analysis of protease nexin-II/amyloid β protein precursor of human carcinoma cell lines, with special reference to the grade of differentiation and metastatic phenotype

    Article • International Journal of Cancer, January 1995, Wiley

    Dr HIROAKI KATAOKA

  108. Establishment of a New Human Urinary Bladder Mixed Carcinoma Cell Line UMK-1 and Its Cell-Density-Dependent Secretion of Gelatinases and Tissue Inhibitor of Metalloproteinase-1

    Article • Urologia Internationalis, January 1995, Karger Publishers

    Dr HIROAKI KATAOKA

  109. Stimulation of TIMP-1 and metalloproteinase production in co-cultures of human tumor cells and human fibroblasts

    Article • Cancer Letters, April 1994, Elsevier

    Dr HIROAKI KATAOKA

  110. Establishment and characterization of a human lung adenocarcinoma cell line (LC-2/ad) producing α1-antitrypsinin vitro

    Article • Pathology International, October 1993, Wiley

    Dr HIROAKI KATAOKA

  111. Properties of α1 -antitrypsin secreted by human adenocarcinoma cell lines

    Article • FEBS Letters, August 1993, Wiley

    Dr HIROAKI KATAOKA

  112. An Autopsy Case Report of Diffuse Esophageal Intramural Pseudodiverticulosis

    Article • Pathology International, November 1992, Wiley

    Dr HIROAKI KATAOKA

  113. Glycocalyceal bodies in a human rectal carcinoma cell line and their interstitial collagenolytic activities

    Article • Virchows Archiv B Cell Pathology Including Molecular Pathology, December 1991, Springer Science + Business Media

    Dr HIROAKI KATAOKA

  114. Establishment of a new human cancer cell line secreting protease nexin-II/amyloid β protein precursor derived from squamous-cell carcinoma of lung

    Article • International Journal of Cancer, September 1991, Wiley

    Dr HIROAKI KATAOKA

  115. Nucleotide sequence of a cDNA for the α subunit of human mitochondrial ATP synthase

    Article • Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, July 1991, Elsevier

    Dr HIROAKI KATAOKA

  116. Prognostic significance of alpha-1-antitrypsin in early stage of colorectal carcinomas

    Article • International Journal of Cancer, February 1990, Wiley

    Dr HIROAKI KATAOKA

  117. New human colorectal carcinoma cell lines that secrete proteinase inhibitors in vitro

    Article • Virchows Archiv B Cell Pathology Including Molecular Pathology, January 1989, Springer Science + Business Media

    Dr HIROAKI KATAOKA